Emergency Medicine / Hematology/Oncology / Oncology

Treatment-Related Adverse Events in Advanced Urothelial Carcinoma

CME: 1.0

September 30, 2022
/ Print / Reprints /
| Share More
/ Text Size+

Upon completion of this activity, participants should be better able to:  

  • Discuss the latest clinical evidence and guidance for treating advanced and metastatic urothelial carcinoma, including the clinical utility, safety-efficacy profiles and target patient populations for current and emerging therapies
  • Individualize disease management decisions for patients with urothelial carcinoma, taking into consideration personal and clinical factors that may influence therapeutic efficacy
  • Recommend evidence-based tactics for identifying, mitigating and managing treatment-related adverse events in a timely and effective manner

Post a comment to this article